Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), resulting from the t(9;22)(q34;q11) translocation and formation of the BCR-ABL fusion gene, accounts for 20%–40% of adult ALL cases (1). This evidence concerns the gene BCR and acute lymphoblastic leukemia.